Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",50051,301,0.67 [0.46-0.96],0.0292389153981702
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51857,401,0.79 [0.57-1.08],0.1360642818409332
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",51324,2797,0.65 [0.58-0.73],1.539831140578216e-12
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Candidiasis,51896,867,0.81 [0.65-1.00],0.0528730140677339
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,50327,7092,0.72 [0.66-0.77],1.4185236410193155e-17
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50520,6469,0.71 [0.65-0.76],8.789642965791144e-18
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51383,2464,0.65 [0.57-0.74],4.793694461376344e-11
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51710,175,0.53 [0.33-0.85],0.0081705101931096
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47746,1964,0.64 [0.55-0.74],1.666454826346569e-09
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,46123,2227,0.54 [0.47-0.62],6.015237065138865e-19
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45871,522,0.76 [0.57-1.00],0.0509326753103238
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36447,4007,0.66 [0.60-0.74],3.820161542368693e-15
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45562,791,0.53 [0.42-0.67],4.163946385062492e-08
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51824,2905,0.68 [0.61-0.77],3.5218158570134767e-10
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Mycoses,52054,1025,0.77 [0.63-0.94],0.011149637768597
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50403,1876,0.51 [0.44-0.59],3.36762801753406e-19
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51917,2167,0.67 [0.58-0.77],7.222809530020209e-09
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49322,403,0.75 [0.55-1.03],0.0768523026204402
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,52157,100,0.99 [0.52-1.89],0.9762306989334698
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51644,1894,0.67 [0.58-0.78],1.1596133974476909e-07
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51691,156,1.25 [0.75-2.07],0.3901876057325063
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51994,320,0.82 [0.58-1.17],0.2717788123375174
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51956,282,0.89 [0.61-1.29],0.5341163239298206
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49377,850,0.80 [0.65-1.00],0.0506331435860399
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,49090,563,0.70 [0.53-0.91],0.0078849137270341
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,49141,222,0.46 [0.30-0.70],0.0003170067708478
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,52115,108,1.20 [0.66-2.20],0.549817727222544
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,52026,307,0.67 [0.46-0.96],0.0280242635331896
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Viral warts,51820,101,1.15 [0.60-2.17],0.6763964445229231
FAP,Prolyl endopeptidase FAP,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51849,130,0.43 [0.25-0.75],0.0026175889124262
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm,51562,596,0.78 [0.60-1.01],0.0595069178906254
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51981,118,0.55 [0.31-0.99],0.0447412813111191
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51940,127,1.08 [0.62-1.88],0.7962201413859121
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23979,131,0.58 [0.33-1.02],0.0589176043667553
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51486,2918,0.87 [0.77-0.98],0.0189405348438766
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of meninges,52129,116,0.56 [0.31-1.01],0.0558699438307185
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,52024,133,0.34 [0.20-0.58],7.700744206974518e-05
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,52106,219,0.68 [0.45-1.04],0.0758882083327072
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm of ovary,28044,182,0.61 [0.38-0.98],0.0428894708743897
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Ascending colon,52110,734,0.92 [0.73-1.17],0.4907415713131855
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Caecum,52111,603,0.91 [0.70-1.18],0.4834683013309541
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51939,148,1.11 [0.66-1.87],0.6822734514752615
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Descending colon,52105,440,0.84 [0.62-1.14],0.2684828067632168
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Rectum,52026,710,0.81 [0.64-1.03],0.0902508027832228
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51922,1248,0.91 [0.76-1.09],0.3263661043913261
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Benign neoplasm: Transverse colon,52091,872,1.09 [0.88-1.35],0.4505144496304362
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Carcinoma in situ of breast,22786,138,1.52 [0.87-2.65],0.142995876136946
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22879,170,1.13 [0.69-1.87],0.6246888501579216
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41521,106,0.81 [0.43-1.52],0.5108041759011336
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41554,139,0.44 [0.26-0.75],0.0028738424817272
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",52056,242,0.82 [0.54-1.24],0.3446432624813882
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Haemangioma, any site",52057,237,0.83 [0.55-1.26],0.3884970595561274
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Leiomyoma of uterus,27119,604,1.01 [0.78-1.31],0.9529730473706984
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Lung cancer and mesothelioma,36167,671,0.39 [0.30-0.50],2.150589276576085e-13
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Lymphoid leukaemia,41519,104,0.60 [0.32-1.12],0.1078330943263173
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41795,380,0.95 [0.68-1.33],0.7631635972734567
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41828,413,0.84 [0.61-1.15],0.2735173954159359
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",23014,190,1.24 [0.77-1.98],0.3743079314110988
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41580,165,2.17 [1.32-3.57],0.0023284826016388
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41633,218,0.54 [0.35-0.83],0.0051914427886618
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41612,197,0.84 [0.53-1.32],0.4518847128399009
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22967,143,0.68 [0.40-1.17],0.1678359465431613
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41604,189,0.76 [0.48-1.22],0.2580382237672682
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",20003,1412,1.13 [0.95-1.34],0.1765102957845086
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41648,233,1.28 [0.84-1.97],0.254971517841289
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41564,149,0.78 [0.46-1.31],0.3412179707305299
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41624,209,0.91 [0.58-1.44],0.7005748516255966
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanocytic naevi,51757,406,1.06 [0.77-1.46],0.7311995238254133
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanocytic naevi of trunk,52076,178,1.40 [0.86-2.29],0.1742936978208266
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Melanoma in situ,41485,164,0.57 [0.34-0.95],0.0303771849431713
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41599,184,0.59 [0.37-0.95],0.0301213646685492
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41742,327,0.57 [0.40-0.82],0.0020223052100514
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41871,456,0.54 [0.40-0.73],5.345162029837117e-05
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41616,201,0.71 [0.45-1.12],0.1369296513097863
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,Other benign neoplasms of skin,51791,313,1.04 [0.72-1.50],0.8294632282211032
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43595,2180,0.88 [0.77-1.02],0.0824974675106541
FAP,Prolyl endopeptidase FAP,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43712,2297,0.89 [0.78-1.03],0.1098504040545743
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51564,694,0.68 [0.54-0.87],0.0019855864997066
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48330,225,0.78 [0.51-1.20],0.2618076835359565
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,51013,143,0.99 [0.58-1.68],0.9715320407038012
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50548,5858,0.66 [0.61-0.72],1.8091391373947845e-22
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,49177,99,0.54 [0.29-1.03],0.0612709544817551
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,51312,101,0.39 [0.21-0.72],0.0027801895899737
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,51170,3065,0.64 [0.57-0.72],3.441690895287622e-14
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,51168,3063,0.64 [0.57-0.72],5.405085850039733e-14
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,48281,176,0.87 [0.53-1.42],0.5739348021188702
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51495,2417,0.57 [0.50-0.65],1.888176668605244e-17
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51440,229,0.73 [0.48-1.11],0.1364283340363027
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,51001,131,0.76 [0.44-1.33],0.3404862622687852
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50990,120,0.87 [0.48-1.56],0.6347723210171756
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51769,558,0.64 [0.49-0.84],0.0011617612623374
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51941,113,0.48 [0.27-0.86],0.0137751437785925
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51671,460,0.66 [0.49-0.88],0.0052139917212968
FAP,Prolyl endopeptidase FAP,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,49292,214,0.45 [0.29-0.69],0.0002344778964524
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40352,644,0.51 [0.40-0.66],1.4181247385329593e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48635,233,0.65 [0.43-0.99],0.0423968427853889
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48659,257,1.05 [0.70-1.57],0.8119136357464931
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39819,111,0.47 [0.26-0.86],0.014002122588331
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48428,138,0.61 [0.36-1.04],0.0679483165100569
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,47279,480,0.33 [0.25-0.44],1.541419167812234e-14
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",51195,1142,0.68 [0.56-0.82],5.745626787379007e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50592,539,0.67 [0.50-0.88],0.0046042305145511
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,50313,260,0.51 [0.34-0.76],0.001037628327969
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51441,3151,0.75 [0.67-0.84],6.351646842925112e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45442,3057,0.70 [0.62-0.79],2.2673522713290282e-09
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39843,135,1.21 [0.69-2.13],0.5008677771964318
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",48079,157,0.78 [0.46-1.29],0.3300907998831496
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,40274,566,0.42 [0.33-0.55],2.3136356749825518e-10
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39832,124,2.42 [1.34-4.35],0.0032231785362968
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46846,7138,0.89 [0.83-0.96],0.0036545258428925
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,40100,392,0.49 [0.36-0.68],1.3185564008986082e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40830,1122,0.58 [0.48-0.70],1.4523330074590662e-08
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51992,660,0.58 [0.45-0.74],1.3029528679700004e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51611,279,0.49 [0.34-0.71],0.0001647260011753
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39964,256,0.61 [0.41-0.92],0.0175606515745148
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39830,122,0.65 [0.45-0.92],0.0156403499008277
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,51064,3142,0.81 [0.72-0.91],0.0003051550992912
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,40234,526,0.53 [0.40-0.69],4.686293602377511e-06
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40314,606,0.72 [0.56-0.94],0.0150223347978199
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40991,1283,0.91 [0.76-1.09],0.2929395569169516
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39949,241,0.93 [0.61-1.42],0.7476421588457577
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51594,262,0.52 [0.35-0.76],0.0007795777369415
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40922,1214,0.78 [0.64-0.94],0.0079268609073967
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40677,969,0.58 [0.47-0.71],2.590791845830401e-07
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46939,140,1.00 [0.58-1.72],0.9877472426135764
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49766,10058,0.83 [0.78-0.88],9.272154284729852e-09
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,48022,100,0.59 [0.31-1.11],0.1033524689189967
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,48035,113,0.91 [0.49-1.66],0.7471378541596935
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51775,3940,0.83 [0.75-0.91],0.0001940715465866
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51777,3935,0.83 [0.75-0.91],0.0001975035716182
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,48027,105,0.81 [0.43-1.50],0.4966222911062855
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51458,2439,0.68 [0.60-0.78],5.748213741606154e-09
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42905,3197,0.64 [0.57-0.71],6.009600561391316e-15
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,52131,460,1.00 [0.75-1.34],0.983524758014156
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,50221,168,0.82 [0.50-1.35],0.4450160313306384
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,49228,209,0.74 [0.47-1.14],0.1727655999191273
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,49306,287,0.83 [0.57-1.21],0.3390528766552365
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",40042,334,0.47 [0.33-0.66],2.072758978490892e-05
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47449,310,1.08 [0.75-1.55],0.6786656783740517
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4283,174,0.99 [0.64-1.53],0.9688381188882164
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4564,512,1.05 [0.81-1.35],0.716148822738345
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,47267,128,1.10 [0.63-1.92],0.7426623826762047
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4221,115,1.33 [0.78-2.28],0.293545713217795
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50857,3718,1.20 [1.08-1.33],0.0006155105737568
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50764,711,0.58 [0.45-0.73],7.059133631385147e-06
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47538,739,0.67 [0.53-0.84],0.0006177549393227
FAP,Prolyl endopeptidase FAP,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,41266,1558,0.61 [0.52-0.72],3.646047677212068e-09
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51929,490,0.74 [0.55-0.98],0.0381794707941421
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49875,332,0.48 [0.34-0.68],4.655367015508045e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Angina pectoris,47633,2416,0.81 [0.71-0.92],0.0012299253952459
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Aortic aneurysm,50026,483,0.55 [0.41-0.73],5.442942233964152e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49663,120,0.86 [0.48-1.54],0.6056715341539605
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49948,405,0.80 [0.58-1.10],0.1750477014524028
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32342,3865,0.71 [0.64-0.79],3.6909359919445536e-10
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,AV-block,43938,878,0.73 [0.58-0.91],0.0050719238193341
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",52039,856,0.82 [0.66-1.02],0.0698033007185506
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cardiac arrest,28865,388,0.61 [0.44-0.86],0.0046918896319353
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43401,341,0.73 [0.52-1.04],0.085410534525975
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",43253,193,0.57 [0.36-0.91],0.0190513991008946
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,52154,103,1.05 [0.56-1.95],0.8863715817919978
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Conduction disorders,45192,2132,0.75 [0.65-0.87],7.325475217242344e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49376,4195,0.83 [0.75-0.91],0.0001508436413269
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45495,15277,0.92 [0.87-0.97],0.0014863375625396
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49357,529,0.74 [0.56-0.97],0.0324111559795328
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Endocarditis,43209,149,0.73 [0.43-1.24],0.2439942291584622
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51739,2227,0.64 [0.56-0.73],3.6402693149335597e-11
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypertension,47354,13130,0.92 [0.87-0.97],0.0025026582053927
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47390,13166,0.91 [0.86-0.97],0.0016534023404412
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51812,160,8.87 [5.56-14.13],4.454627083333097e-20
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34580,356,0.77 [0.54-1.08],0.1229023414803238
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34505,281,0.74 [0.50-1.09],0.1328160225244498
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Hypotension,51865,2380,0.65 [0.57-0.74],8.158119284948278e-11
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,50297,215,0.98 [0.63-1.52],0.9212887994691034
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49722,4505,0.85 [0.77-0.93],0.0007446148022781
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51396,1126,0.81 [0.67-0.98],0.0266054226590383
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43793,733,0.77 [0.61-0.99],0.0374229771200359
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,51185,1693,0.85 [0.73-0.99],0.0374880792741401
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46646,1429,0.78 [0.66-0.93],0.0051930315746429
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51968,314,0.93 [0.65-1.34],0.7025004612552349
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",52097,622,0.76 [0.59-0.98],0.0370114809092912
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Oesophageal varices,48938,110,8.85 [5.08-15.41],1.3429204646733007e-14
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other aneurysm,49702,159,0.65 [0.39-1.08],0.0959254300804857
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other arrhythmias,43914,854,0.59 [0.47-0.73],2.699871258850969e-06
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49747,204,0.61 [0.39-0.95],0.0298799802756461
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,50026,483,0.96 [0.71-1.28],0.7612514830976187
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43420,360,0.79 [0.56-1.11],0.1709216642504696
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other disorders of veins,49025,197,0.93 [0.59-1.46],0.7542551770579633
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48926,98,0.61 [0.32-1.16],0.130775056823223
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,49261,130,0.91 [0.52-1.60],0.7451853298879452
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,49106,278,0.64 [0.44-0.94],0.0216245574974058
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,45151,2091,0.61 [0.53-0.70],4.118440680072953e-12
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49597,112,7.66 [4.37-13.44],1.2061852599706368e-12
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50643,1100,0.69 [0.57-0.84],0.0001901462919127
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50915,698,0.59 [0.47-0.75],1.6085573001191013e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50368,1237,0.72 [0.60-0.86],0.0004243383178726
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,29154,677,0.46 [0.36-0.59],2.281129152821508e-09
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Peripheral artery disease,50301,820,0.77 [0.62-0.96],0.0202707222935688
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49522,694,0.75 [0.59-0.96],0.0228076999187553
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Pulmonary embolism,51173,956,0.93 [0.75-1.14],0.4718848542532178
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,52016,1326,0.68 [0.57-0.81],2.022009811537348e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43766,706,0.67 [0.52-0.85],0.0012317188872789
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50904,687,0.59 [0.47-0.75],1.6307832242570132e-05
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49520,389,0.63 [0.46-0.87],0.0054503906435124
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51373,1291,0.82 [0.68-0.98],0.0268180023727117
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",51331,1369,0.84 [0.71-1.00],0.0457069087123007
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,50240,120,1.17 [0.65-2.11],0.5993880898556287
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49703,161,0.65 [0.39-1.08],0.0954100210323593
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50746,476,0.85 [0.63-1.14],0.276076554303404
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,50018,526,0.84 [0.64-1.11],0.2217490570018602
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Varicose veins,49684,856,1.04 [0.83-1.30],0.7245174726776844
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49572,173,0.43 [0.26-0.69],0.0005723495170811
FAP,Prolyl endopeptidase FAP,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51696,1512,0.87 [0.74-1.03],0.1039321852255883
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51911,723,0.93 [0.74-1.18],0.5700868419767458
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45626,2883,0.69 [0.61-0.78],1.927342721970162e-09
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Any mental disorder,50836,8093,0.75 [0.70-0.81],3.9849073025092135e-15
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51818,857,0.86 [0.69-1.07],0.1715537505019884
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45952,3209,0.71 [0.63-0.80],3.07587523157262e-09
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42924,181,0.49 [0.31-0.78],0.0025761971575172
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Smoking dependency,51082,2767,0.73 [0.65-0.82],3.1247724741910684e-07
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",46041,3298,0.74 [0.66-0.82],7.544729794709912e-08
FAP,Prolyl endopeptidase FAP,Chapter V Mental and behavioural disorders,Vascular dementia,51121,255,0.66 [0.44-0.99],0.0421993118048112
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Alzheimer disease,52156,670,0.72 [0.56-0.92],0.0087043701650096
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",35137,118,1.16 [0.62-2.18],0.6363516376800714
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Bell's palsy,48549,164,0.68 [0.42-1.12],0.1279615120969107
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49385,1000,1.21 [0.99-1.48],0.0647630442071654
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Cerebral cysts,51333,465,0.89 [0.66-1.20],0.4456009597535348
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51994,648,0.61 [0.47-0.78],7.4176229667674e-05
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,51141,101,0.82 [0.43-1.57],0.5487125837961666
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,52122,122,1.12 [0.63-1.99],0.7016682615347958
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",51017,149,0.99 [0.58-1.68],0.9744903308065958
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Epilepsy,48993,575,0.95 [0.72-1.24],0.6965745038959781
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,51181,2763,0.87 [0.77-0.98],0.0199653422266638
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,52073,1218,0.66 [0.55-0.79],8.401308441690117e-06
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50948,5196,0.76 [0.70-0.83],2.786526558949936e-09
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Generalized epilepsy,51386,108,1.04 [0.56-1.94],0.8913450314176705
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Hemiplegia,51853,507,0.63 [0.48-0.84],0.0014093351524909
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Hydrocephalus,50990,122,0.99 [0.55-1.78],0.977957109630856
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,52118,138,1.47 [0.85-2.55],0.1641675405125532
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48535,150,0.75 [0.44-1.27],0.2802999597418666
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48549,164,0.78 [0.48-1.28],0.3224202676269226
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Memory loss,50830,219,1.07 [0.69-1.65],0.7731893654021688
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Migraine,49139,721,0.90 [0.71-1.15],0.4109466429903483
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",52013,649,0.87 [0.68-1.12],0.2763670798310845
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Motor neuron disease,35338,279,1.23 [0.82-1.84],0.310782390538226
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51820,211,0.39 [0.25-0.61],2.681424488599161e-05
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50807,2422,0.99 [0.87-1.12],0.8268176050602548
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Neurological diseases,49166,7623,0.82 [0.76-0.89],2.512975000789199e-07
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51446,406,0.68 [0.49-0.93],0.0159572851989572
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",49216,831,0.94 [0.76-1.18],0.6111545380689694
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",52001,599,1.15 [0.89-1.49],0.2929039749370346
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41477,1312,0.61 [0.51-0.73],5.721170316514622e-08
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,51019,151,0.84 [0.50-1.41],0.5044088890529057
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other disorders of nervous system,51147,279,0.94 [0.64-1.37],0.7310100715211689
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,51188,333,0.68 [0.47-0.96],0.0289496606732325
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48578,193,0.71 [0.45-1.12],0.1409086987418821
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other headache syndromes,48533,115,0.64 [0.36-1.16],0.1400610652021575
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other neurological diseases,51913,1045,0.79 [0.65-0.96],0.0178957228203217
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Other sleep disorders,49546,1128,0.83 [0.69-1.00],0.0452945980072455
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Parkinson's disease,52112,860,0.64 [0.51-0.80],6.666054495190817e-05
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50980,112,0.76 [0.42-1.40],0.3826688467684367
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Restless leg syndrome,52155,157,0.67 [0.40-1.11],0.1183145134870601
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Sleep apnoea,51661,969,0.84 [0.69-1.03],0.0916604465716278
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51501,99,1.38 [0.71-2.66],0.3406913231816368
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,52128,334,1.32 [0.93-1.88],0.1259026424314582
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48487,102,0.92 [0.49-1.75],0.8027485565604999
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,52156,677,0.71 [0.55-0.91],0.0064491821179759
FAP,Prolyl endopeptidase FAP,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),51045,248,0.65 [0.43-0.97],0.0370068274882719
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,51002,199,0.49 [0.31-0.77],0.0020051765046071
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,51328,793,0.97 [0.77-1.22],0.7661790799599563
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51801,473,1.11 [0.83-1.48],0.4741532382695278
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,50132,108,0.90 [0.48-1.67],0.7298012737327918
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50139,115,1.19 [0.65-2.18],0.5680482015541274
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51939,106,0.47 [0.26-0.87],0.0153063587482385
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51626,293,1.10 [0.75-1.61],0.6203754373751571
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4232,123,1.39 [0.83-2.34],0.2093083015038199
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5135,206,1.20 [0.81-1.79],0.3635275425507011
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50990,187,0.93 [0.58-1.48],0.746355169896489
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51715,2089,0.81 [0.70-0.93],0.0034752831809096
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51420,1396,0.73 [0.62-0.87],0.0003552974800786
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50473,449,0.63 [0.46-0.85],0.0022516791057334
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51984,1449,0.94 [0.79-1.11],0.4646281360305876
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,52136,137,0.80 [0.46-1.38],0.4153765545213472
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51834,1299,0.92 [0.77-1.10],0.3489560603308217
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",52068,735,0.97 [0.76-1.23],0.8044651622859457
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51970,360,1.07 [0.76-1.50],0.709242762553721
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,50143,119,0.55 [0.30-0.98],0.0432903219638798
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,50160,136,0.53 [0.30-0.91],0.0217358398041937
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,50133,109,0.53 [0.29-0.97],0.0397437814419764
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51966,1427,1.14 [0.96-1.35],0.1428345335228188
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50912,373,1.00 [0.71-1.39],0.9797935627693284
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50635,100,0.77 [0.40-1.47],0.4270496033153719
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51535,202,1.21 [0.77-1.91],0.4161166825207366
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51880,547,0.92 [0.70-1.22],0.5660077245305741
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50920,385,0.94 [0.67-1.30],0.6975781252089069
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51832,222,1.00 [0.65-1.54],0.9935778514896316
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51489,950,1.15 [0.93-1.42],0.1924129111720308
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,51087,284,0.84 [0.58-1.23],0.3707768831118667
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48936,4383,0.92 [0.84-1.02],0.0993619858943246
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51809,476,0.98 [0.73-1.32],0.904031341409022
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,52115,308,1.05 [0.73-1.52],0.7837120726785618
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50851,827,0.76 [0.61-0.95],0.0153979054176769
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51465,132,1.39 [0.79-2.46],0.2496032843275138
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,52110,111,0.86 [0.47-1.58],0.6220017480429132
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,50195,171,1.14 [0.69-1.87],0.6089262876991623
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50323,299,1.10 [0.76-1.60],0.6123767059837163
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49864,238,0.91 [0.60-1.39],0.6662226268411926
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50660,125,1.29 [0.72-2.31],0.3875363170803374
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49752,126,1.28 [0.72-2.29],0.4031247861207835
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50714,175,0.79 [0.49-1.29],0.3483914375802863
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50933,394,1.13 [0.81-1.56],0.4796572608332363
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,50282,258,0.72 [0.49-1.07],0.1068949204833332
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49849,223,1.04 [0.67-1.61],0.8749358994638923
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49798,172,0.97 [0.59-1.59],0.8915493028244718
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,48181,3628,0.90 [0.81-1.01],0.0670865424691113
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,50165,141,0.57 [0.33-0.98],0.0403046497815752
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51632,829,0.76 [0.61-0.95],0.0146451428804826
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50919,116,1.05 [0.58-1.91],0.8724508354166775
FAP,Prolyl endopeptidase FAP,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),51146,343,0.79 [0.56-1.12],0.1813439637433958
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51730,177,0.52 [0.32-0.83],0.0067577800254338
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,52066,242,0.88 [0.58-1.33],0.5413440436862754
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51891,259,1.08 [0.73-1.61],0.6869807206076723
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51674,121,1.05 [0.59-1.89],0.8666271459920494
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,51678,125,0.97 [0.55-1.74],0.930507862540629
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51958,1819,0.76 [0.65-0.88],0.000387230389798
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51441,1302,0.75 [0.63-0.90],0.0019445309379353
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50393,254,0.76 [0.51-1.14],0.1870822024496876
FAP,Prolyl endopeptidase FAP,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,50312,173,0.82 [0.50-1.33],0.4188832883221705
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute pharyngitis,51665,152,0.99 [0.59-1.66],0.9790566687049428
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51944,431,1.17 [0.86-1.58],0.3219878083726437
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51642,129,1.72 [0.99-3.01],0.0562425746910242
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,All influenza,48077,239,0.51 [0.34-0.76],0.0011100857752669
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),48072,234,0.53 [0.35-0.80],0.0026817614663655
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35733,237,0.51 [0.33-0.77],0.0016487558398261
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Allergic rhinitis,51889,565,0.92 [0.70-1.21],0.5639834748583878
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38518,3565,0.54 [0.48-0.60],1.5646712219588131e-28
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",39009,3513,0.55 [0.49-0.61],3.793852520542179e-27
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),51330,280,0.46 [0.31-0.66],3.836482259996072e-05
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",48002,164,0.33 [0.20-0.54],7.397957376187684e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Bronchiectasis,45213,719,0.41 [0.32-0.52],1.2295016513583716e-13
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44612,118,0.59 [0.42-0.83],0.0027964368433529
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,50111,5617,0.58 [0.53-0.63],5.762348849886363e-37
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49381,142,0.85 [0.49-1.46],0.5552253291967291
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Chronic sinusitis,49551,312,0.84 [0.59-1.21],0.3544364472276964
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51751,2399,0.52 [0.46-0.59],3.7450085140906185e-23
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Deviated nasal septum,49454,215,0.71 [0.46-1.09],0.1175019764277305
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47983,10611,0.68 [0.63-0.72],8.219497207217856e-34
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49976,737,0.74 [0.59-0.94],0.0136887583661557
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Early onset COPD,49987,635,0.67 [0.53-0.86],0.0013474534136266
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Emphysema,45130,636,0.41 [0.32-0.53],6.522842120728749e-12
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49538,579,0.57 [0.43-0.74],2.844935541574817e-05
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51706,3868,0.60 [0.54-0.66],3.660662737281338e-23
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Interstitial lung disease,49609,650,0.59 [0.46-0.76],4.919009628321616e-05
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Later onset COPD,50131,1764,0.49 [0.42-0.57],3.322171350699065e-20
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,52132,667,0.54 [0.43-0.70],1.1614801835306128e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Nasal polyp,49454,215,0.93 [0.60-1.44],0.728985851144438
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51651,1966,0.68 [0.59-0.79],1.442169540633601e-07
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other diseases of pleura,51676,4017,0.66 [0.59-0.73],2.559836527704073e-16
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50925,1686,0.79 [0.68-0.92],0.0029896501985943
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other pleural conditions,47762,103,0.51 [0.27-0.96],0.0367414232350785
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51978,809,0.60 [0.48-0.75],8.132633282741049e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51939,2614,0.60 [0.53-0.68],1.3153309933256629e-15
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pleural effusion,49665,2006,0.66 [0.57-0.76],1.12449226075112e-08
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pleural plaque,47973,314,0.58 [0.40-0.83],0.0031935634567579
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",51195,3357,0.57 [0.51-0.64],3.224724181622217e-23
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,52001,536,0.53 [0.40-0.69],3.849970876585846e-06
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pneumothorax,47895,236,0.47 [0.31-0.72],0.0004727797941314
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pollen allergy,52107,482,0.88 [0.66-1.19],0.4115826565652853
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Pulmonary oedema,51303,134,0.72 [0.42-1.23],0.2268381644299002
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35604,108,0.54 [0.37-0.79],0.0016521331368501
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51607,1922,0.68 [0.59-0.79],2.026129005097437e-07
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49806,567,0.92 [0.70-1.20],0.5343650346276089
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Viral pneumonia,48344,506,0.63 [0.48-0.84],0.0013291854144703
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51360,416,0.71 [0.52-0.96],0.0284860595289557
FAP,Prolyl endopeptidase FAP,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,24034,229,0.53 [0.35-0.83],0.0047280997665382
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36848,129,0.59 [0.34-1.03],0.0650953965924896
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute appendicitis,51831,292,0.78 [0.53-1.14],0.1991050171007566
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute gastritis,39233,182,0.92 [0.57-1.50],0.7440848418662471
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute pancreatitis,48430,372,0.62 [0.45-0.86],0.0040818927672764
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Acute peritonitis,51203,186,1.15 [0.72-1.84],0.5480420496907361
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50349,150,4.46 [2.71-7.34],4.0975795915412954e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Barrett oesophagus,39935,884,0.72 [0.57-0.89],0.0027440976196627
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",48264,206,0.44 [0.28-0.67],0.0001890179900546
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",51311,206,0.45 [0.29-0.70],0.000323055422745
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Cholecystitis,48472,414,0.59 [0.43-0.80],0.0007204678853117
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Cholelithiasis,50061,2003,0.70 [0.61-0.81],1.002270129846614e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Chronic gastritis,39673,622,0.82 [0.63-1.07],0.1381990365505124
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Chronic pancreatitis,48157,99,0.82 [0.43-1.55],0.5430850895226533
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51866,214,5.45 [3.58-8.28],2.047420138584228e-15
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Coeliac disease,48913,250,0.35 [0.23-0.52],2.723924965556705e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Collagenous colitis,48770,167,0.84 [0.51-1.39],0.4932361205360467
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51846,379,0.72 [0.52-0.99],0.0446628596957147
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Constipation,51634,3388,0.69 [0.62-0.77],4.0764706028059975e-11
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Crohn disease,48792,189,0.51 [0.32-0.82],0.0049370167208487
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51445,139,0.63 [0.37-1.08],0.0917541531811927
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48781,178,0.68 [0.42-1.09],0.1099212046793958
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Dental caries,50647,461,0.89 [0.67-1.20],0.4467928233402564
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46800,4498,0.73 [0.66-0.80],1.0008060738595468e-10
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of appendix,51904,365,0.80 [0.57-1.12],0.1920605265607532
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of liver,51909,1710,1.15 [0.98-1.34],0.0786193006245279
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47769,8718,0.81 [0.76-0.87],6.426147885864451e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",51308,1122,1.08 [0.89-1.30],0.43721207407752
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51981,964,0.71 [0.58-0.87],0.0008658434755044
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50416,230,1.04 [0.68-1.58],0.853662195163732
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of salivary glands,50120,132,0.51 [0.30-0.88],0.0150770850242417
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51524,2861,0.70 [0.63-0.79],8.390128771313968e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diseases of tongue,50150,224,1.00 [0.65-1.54],0.986884255797173
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50893,2835,0.70 [0.62-0.79],5.697159005117988e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,43092,6373,0.74 [0.68-0.80],4.969676355269517e-13
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Duodenal ulcer,39452,401,0.80 [0.58-1.10],0.1720413122554175
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51987,323,0.91 [0.64-1.30],0.6044063384254887
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51973,114,1.04 [0.57-1.91],0.8989583130329746
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50458,259,3.30 [2.24-4.87],1.6780878165893591e-09
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,37017,298,0.66 [0.46-0.96],0.027499646452841
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Functional dyspepsia,40154,1103,0.79 [0.65-0.96],0.0201537903424057
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastric ulcer,39779,728,0.75 [0.59-0.96],0.019592717131527
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,44103,5052,0.77 [0.70-0.84],1.5141867315455896e-08
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,40139,1088,0.74 [0.61-0.89],0.0020865962272282
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40371,16737,0.82 [0.78-0.87],8.279781024917704e-14
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,GI-bleeding,51008,2345,0.77 [0.67-0.87],6.952129782409012e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,50294,108,0.70 [0.38-1.27],0.2388919245068189
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38680,2533,0.78 [0.69-0.89],0.0001788241763426
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",50326,127,5.79 [3.35-10.02],3.3881979280499915e-10
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Hernia,48855,6553,0.73 [0.67-0.79],8.148919250501873e-15
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Impacted teeth,51987,106,1.02 [0.54-1.92],0.9441871828645048
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Impaction of intestines,36832,113,0.68 [0.37-1.25],0.2153814792007398
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Inguinal hernia,44125,1823,0.71 [0.61-0.83],1.5900702781021248e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42510,208,0.73 [0.46-1.15],0.1781762705744815
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36912,193,0.46 [0.29-0.73],0.0008802144579231
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48953,290,0.37 [0.26-0.54],2.156896534479307e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37827,1108,0.74 [0.61-0.90],0.0024027957515395
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,52096,750,1.36 [1.08-1.71],0.0083739399754578
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,50126,1523,0.85 [0.72-1.00],0.0518154151854098
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50628,2025,0.82 [0.71-0.94],0.0050782282582357
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39432,381,0.67 [0.48-0.94],0.0185441986836212
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oesophagitis,40269,1218,0.73 [0.61-0.88],0.0009626331087802
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,52054,270,0.79 [0.53-1.16],0.2321924250535597
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42440,138,0.39 [0.23-0.67],0.0005155764666237
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39457,2738,0.80 [0.71-0.91],0.0005809790461531
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48627,569,0.51 [0.39-0.67],7.039638040114873e-07
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48376,318,0.69 [0.48-0.98],0.0386027637632818
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of intestine,40238,3519,0.77 [0.69-0.86],4.247729703718862e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of intestines,48105,11386,0.79 [0.74-0.84],6.905896082489988e-15
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,50100,413,0.85 [0.62-1.17],0.3267107618700641
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of liver,51604,1405,1.23 [1.04-1.46],0.0171065935994181
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40394,1343,0.67 [0.56-0.80],1.1769525004829245e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48365,307,0.74 [0.51-1.07],0.1052387944542888
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51845,828,0.64 [0.52-0.80],8.07761476773321e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40977,1926,0.90 [0.78-1.05],0.1783941550971785
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,51039,2376,0.76 [0.67-0.87],5.122492144501031e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50563,377,1.01 [0.73-1.40],0.9513991050336928
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,40202,3483,0.65 [0.59-0.73],2.2298064616289235e-14
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),43109,4058,0.75 [0.67-0.82],1.15625047595604e-08
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50401,202,2.12 [1.35-3.32],0.0010477968002043
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50381,1778,0.86 [0.73-1.00],0.0431259457241861
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37415,696,0.65 [0.51-0.83],0.0005810462483908
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51953,134,1.12 [0.64-1.97],0.6827213067129387
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37709,990,0.61 [0.49-0.74],1.7019933026729823e-06
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48960,297,0.68 [0.47-0.98],0.0390555043836163
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Recurring oral aphthae,52134,114,0.70 [0.38-1.26],0.2304884438060684
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,50198,237,1.01 [0.66-1.53],0.970882057789982
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Toxic colitis,48717,114,0.58 [0.32-1.06],0.075579167567448
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39589,538,0.69 [0.52-0.92],0.0099567120329686
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ulcerative colitis,48926,323,0.51 [0.36-0.72],0.0001707223578514
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48870,267,0.57 [0.38-0.84],0.0047775367462979
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Umbilical hernia,42852,550,0.58 [0.44-0.75],4.850708714788933e-05
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,37074,355,0.66 [0.47-0.93],0.0171389370855542
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Ventral hernia,42831,529,0.65 [0.49-0.85],0.0020468889854369
FAP,Prolyl endopeptidase FAP,Chapter XI Diseases of the digestive system,Volvulus,36879,160,0.72 [0.43-1.21],0.2145717510795991
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51988,597,0.95 [0.72-1.24],0.6954431881183007
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51504,148,1.10 [0.66-1.86],0.7113388664241354
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,48013,320,1.13 [0.79-1.64],0.4994561103247369
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50861,1414,0.87 [0.74-1.03],0.1166443852300149
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49798,351,1.03 [0.74-1.45],0.8525662933973265
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48514,821,0.61 [0.49-0.76],1.3226637839399907e-05
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51533,563,1.00 [0.77-1.31],0.9827576191262518
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51952,982,0.85 [0.70-1.05],0.1262290786754613
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,51069,99,0.45 [0.24-0.84],0.0117403295436057
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,49003,6477,0.83 [0.76-0.89],2.99994760616376e-06
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51237,904,0.74 [0.60-0.91],0.005214800386794
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50970,637,0.72 [0.56-0.93],0.0118666852878035
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51360,1913,0.91 [0.78-1.05],0.1821850285002038
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",52122,111,0.80 [0.43-1.46],0.461363635939364
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47806,113,0.56 [0.40-0.78],0.0005728240578939
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50438,105,1.00 [0.54-1.86],0.9941240047920396
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51512,542,1.07 [0.81-1.41],0.618100258273022
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48612,919,0.81 [0.66-1.01],0.0621994079675954
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47823,130,0.88 [0.50-1.57],0.6767228371690922
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51981,167,0.78 [0.48-1.26],0.3083339053082011
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49834,387,0.75 [0.54-1.04],0.0822202166390177
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51745,389,1.06 [0.77-1.47],0.7238654115336192
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,51100,130,0.53 [0.30-0.92],0.0232355866375709
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47828,135,0.76 [0.43-1.33],0.3308196928517685
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50987,3294,0.77 [0.69-0.86],5.754296505868857e-06
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48689,996,0.80 [0.65-0.98],0.0351335671933785
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47831,138,0.78 [0.45-1.37],0.3934937610495153
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51975,619,0.94 [0.73-1.22],0.6537573786617283
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,51111,141,0.94 [0.55-1.61],0.8292054229452397
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51862,506,1.01 [0.76-1.35],0.9300256626552968
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,52045,654,0.93 [0.72-1.20],0.5735923143910762
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47944,251,1.35 [0.89-2.04],0.1604421756619208
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,48238,545,1.00 [0.76-1.33],0.9867490760576656
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,52023,632,0.94 [0.72-1.22],0.6225480419860125
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",48170,477,1.00 [0.75-1.34],0.9814986732821068
FAP,Prolyl endopeptidase FAP,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,52094,280,0.74 [0.51-1.08],0.1187325722470874
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44747,223,0.56 [0.37-0.86],0.0077195925683474
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47464,11387,0.98 [0.92-1.04],0.4719523643983305
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44603,8526,1.00 [0.93-1.07],0.9833087032094804
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44675,151,0.69 [0.41-1.16],0.1573792694995279
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,45208,308,1.25 [0.86-1.80],0.2409603546289874
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,45263,363,0.94 [0.67-1.32],0.733539274098189
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51653,187,1.16 [0.73-1.84],0.5250429887142816
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",45100,200,0.52 [0.33-0.82],0.0046457789197903
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38362,2285,1.24 [1.08-1.42],0.0023034392250352
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51878,377,1.34 [0.96-1.88],0.0818794519356751
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45797,897,0.79 [0.63-0.98],0.030479406866876
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,44076,14659,0.91 [0.86-0.96],0.0006123070998454
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,48156,235,0.69 [0.45-1.05],0.0800043107091985
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44828,304,0.63 [0.44-0.91],0.0137021691699404
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45673,1149,1.18 [0.98-1.43],0.081802296626432
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,50278,5378,0.84 [0.77-0.92],9.223525332976248e-05
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,45072,548,1.13 [0.86-1.50],0.3780830506911414
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44973,449,0.67 [0.50-0.90],0.0087695248184816
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44800,276,1.11 [0.75-1.65],0.5927140230741661
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50858,140,0.42 [0.25-0.72],0.0017322906799231
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39488,3411,1.08 [0.97-1.21],0.1701911287386123
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37303,1226,0.89 [0.74-1.07],0.2082672903973054
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",52001,1209,0.86 [0.72-1.03],0.0964545326358828
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36230,153,1.23 [0.72-2.10],0.446386925024809
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36745,668,1.27 [0.98-1.64],0.069348817599313
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,45134,610,1.07 [0.82-1.38],0.6206763255044061
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37363,1286,1.33 [1.11-1.59],0.0020545259999283
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,45012,112,0.74 [0.40-1.37],0.3368575615786014
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,46170,1270,0.87 [0.73-1.04],0.1325873400881619
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45511,611,0.81 [0.63-1.05],0.1178225522518269
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37279,1202,1.33 [1.11-1.61],0.0025363933456295
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44686,162,0.69 [0.42-1.14],0.1486821661270093
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44647,123,0.73 [0.41-1.29],0.2780400164460999
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,48067,146,1.41 [0.84-2.37],0.1970914626930028
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51373,3452,0.68 [0.61-0.76],6.918937675405902e-12
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,50180,2259,0.57 [0.50-0.65],5.353847937968007e-16
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51870,907,0.60 [0.49-0.74],1.8445868137966912e-06
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,41103,5026,0.87 [0.79-0.95],0.002700028209421
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,36203,126,1.24 [0.69-2.21],0.4745730881812263
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44714,190,0.82 [0.52-1.31],0.4109535000811326
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,36177,100,1.38 [0.71-2.66],0.3442836025956624
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36329,252,1.26 [0.83-1.91],0.2783863803357821
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48408,487,0.93 [0.70-1.25],0.6416607014451131
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48691,770,0.55 [0.43-0.69],4.378664179235935e-07
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,52089,202,1.10 [0.70-1.73],0.6775787836086546
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48549,3649,0.86 [0.78-0.96],0.0062323313192468
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44727,203,1.04 [0.66-1.63],0.8669667761757833
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36355,278,0.96 [0.64-1.42],0.8317076197160126
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46364,1464,0.89 [0.75-1.05],0.1680331811851949
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40413,4336,1.07 [0.97-1.18],0.1928246122650646
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50909,191,0.41 [0.26-0.64],0.0001186717489788
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,52117,141,1.23 [0.72-2.10],0.4479225342225035
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44689,165,1.46 [0.89-2.40],0.1336507075457504
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",47043,2519,0.75 [0.66-0.86],1.2376515051088452e-05
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44703,179,0.65 [0.40-1.04],0.0745025504000196
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39352,3275,0.87 [0.77-0.97],0.0132359674034836
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,48145,224,0.83 [0.54-1.27],0.3910134000273005
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44632,108,1.34 [0.72-2.51],0.3558518469221549
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,45220,320,0.77 [0.54-1.11],0.1642672121935858
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45639,1115,0.71 [0.59-0.86],0.0004471939543026
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51433,715,0.49 [0.39-0.62],6.162276956955864e-09
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,46056,1156,0.97 [0.80-1.17],0.7310715140934991
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51894,881,0.59 [0.48-0.73],1.0563319813610654e-06
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,52111,109,0.66 [0.48-0.91],0.0115914522361019
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44907,383,0.89 [0.64-1.24],0.4862003005058525
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41264,1522,0.81 [0.69-0.95],0.0104275483972018
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45694,1170,0.82 [0.68-0.98],0.0326311964452112
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44982,458,1.28 [0.94-1.74],0.1213882857041087
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",36185,108,1.03 [0.55-1.94],0.9187532120561198
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,41101,5024,0.85 [0.78-0.93],0.0006060540813883
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37397,1320,1.07 [0.89-1.27],0.4913669354032124
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,51186,468,0.64 [0.48-0.87],0.004015744719858
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",52021,134,1.07 [0.61-1.88],0.8085072286199027
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47779,102,1.06 [0.57-1.96],0.8632741611921455
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,36221,144,1.13 [0.66-1.94],0.6567343949954074
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,45103,203,0.72 [0.46-1.14],0.1602469534575158
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36996,919,0.59 [0.48-0.73],1.2169071120850668e-06
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,45143,619,1.07 [0.82-1.38],0.6305609804110408
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45414,514,0.76 [0.57-1.01],0.0560955436377148
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,45281,381,0.67 [0.48-0.94],0.0191398618152398
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40762,118,0.62 [0.34-1.13],0.1183152512832418
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",52119,117,0.67 [0.49-0.92],0.0147149632960345
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45712,1188,0.97 [0.81-1.17],0.7637323411566391
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],50903,185,0.30 [0.19-0.48],2.428934660576878e-07
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49717,5193,0.92 [0.84-1.00],0.0544817426081603
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44789,265,0.58 [0.39-0.85],0.0058199387067878
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45998,1098,1.09 [0.90-1.32],0.394735626721043
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,49318,474,0.74 [0.55-0.99],0.0405495544301749
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45316,416,1.15 [0.83-1.58],0.4020544361025562
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,48041,3141,0.85 [0.76-0.95],0.0057797652392576
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46963,2063,0.85 [0.74-0.98],0.0235543299142772
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44635,111,1.42 [0.77-2.61],0.2569472366821652
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50989,271,0.32 [0.22-0.47],3.0548530033944475e-09
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44852,328,1.46 [1.02-2.09],0.0361290003750102
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44677,153,0.58 [0.35-0.96],0.035243978833838
FAP,Prolyl endopeptidase FAP,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),36194,117,1.19 [0.65-2.19],0.5688529668137172
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Acute renal failure,50025,3181,0.67 [0.60-0.75],4.100972496642847e-12
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21059,103,1.45 [0.77-2.73],0.255456760404427
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27413,113,0.60 [0.33-1.10],0.0996166787411266
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51512,656,0.68 [0.54-0.88],0.0025422518893771
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,51025,169,0.77 [0.47-1.26],0.3054213181297062
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49944,3100,0.74 [0.66-0.83],3.119711030184881e-07
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51717,166,0.82 [0.50-1.33],0.4171145496637514
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51653,609,0.58 [0.45-0.75],2.782543412110804e-05
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Cystitis,45942,474,0.62 [0.46-0.83],0.0014813515412119
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Dialysis,47008,164,1.24 [0.75-2.03],0.3974523655315223
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22734,3346,0.85 [0.76-0.95],0.0050062646469054
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27646,346,0.65 [0.46-0.91],0.0122252406149013
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Endometriosis,21140,184,1.28 [0.79-2.05],0.3143999094570372
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21361,405,0.55 [0.40-0.77],0.0003404458967442
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21979,1023,0.69 [0.56-0.85],0.0003265621117948
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43527,10831,0.73 [0.68-0.77],5.096863887719967e-24
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51721,170,0.76 [0.47-1.23],0.2689828219141612
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hydrocele,19595,207,0.77 [0.49-1.21],0.2630832350694531
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46826,591,0.62 [0.48-0.81],0.0003876661218496
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,22019,2631,0.81 [0.71-0.92],0.0012281774246741
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27562,411,0.74 [0.54-1.02],0.0650147806553677
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19625,237,0.97 [0.63-1.48],0.88055485772831
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Irregular menses,27649,131,0.49 [0.28-0.87],0.0137978828161478
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21268,312,0.58 [0.40-0.83],0.0034635497274398
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45627,159,0.59 [0.36-0.98],0.0411332125394754
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23470,2514,0.70 [0.61-0.79],3.2557784640624183e-08
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19499,111,0.85 [0.46-1.56],0.5994882020413007
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21104,148,0.44 [0.26-0.74],0.0019059822373391
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",52129,131,0.93 [0.53-1.63],0.7996049040133433
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",52137,135,0.63 [0.36-1.09],0.0957217862510444
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,50033,4565,0.72 [0.66-0.79],2.0365825942458422e-11
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46921,1453,0.68 [0.57-0.80],6.74779346015295e-06
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27420,120,0.79 [0.44-1.42],0.431066081200373
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,52015,971,0.58 [0.47-0.71],1.534317341050806e-07
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19701,313,0.74 [0.51-1.06],0.1022953194883331
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19672,284,0.83 [0.57-1.22],0.3543522615621292
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19620,232,1.07 [0.70-1.65],0.7475940352050077
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,52076,144,0.72 [0.42-1.22],0.220366753751725
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48982,3514,0.69 [0.62-0.77],1.7591056913288295e-11
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27362,211,0.99 [0.64-1.54],0.961816501383904
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21115,159,0.49 [0.30-0.81],0.0051979826199408
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21334,378,0.65 [0.47-0.90],0.0097282370430417
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21071,115,0.89 [0.48-1.63],0.7011285680485781
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21166,210,0.72 [0.46-1.12],0.1463742223402619
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46923,688,0.62 [0.48-0.79],0.0001239905180219
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51367,323,0.53 [0.37-0.75],0.0003196987880421
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21274,318,0.92 [0.64-1.32],0.633075095189242
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21066,110,0.79 [0.43-1.46],0.4541764602016959
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21621,665,0.77 [0.60-0.99],0.0426874388208948
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21121,165,0.69 [0.42-1.14],0.1485117460121408
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21558,602,0.77 [0.60-1.00],0.0529313483284807
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51649,98,0.71 [0.38-1.35],0.2988266190607068
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19656,268,0.96 [0.64-1.42],0.8214924548439311
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51646,5411,0.73 [0.67-0.79],4.059795321565037e-13
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46474,239,0.61 [0.40-0.92],0.0175409126428198
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,47111,267,0.95 [0.64-1.41],0.8002270555795815
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50969,113,0.76 [0.42-1.38],0.3714650248724042
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45915,447,0.90 [0.66-1.23],0.5066394461132695
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51664,808,0.71 [0.57-0.88],0.0023743697713998
FAP,Prolyl endopeptidase FAP,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21103,147,0.60 [0.35-1.00],0.051546514266347
